264 related articles for article (PubMed ID: 36430839)
21. miR-582 Suppresses the Proliferation of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells and Protects Them From Natural Killer Cell-Mediated Cytotoxicity.
Li X; Zhang Y; He F; Gao D; Che B; Cao X; Huang S; Zheng M; Han H
Front Immunol; 2022; 13():853094. PubMed ID: 35514986
[TBL] [Abstract][Full Text] [Related]
22. The regulatory roles of cell surface sialylation and N-glycans in human B cell lymphoma cell adhesion to galectin-1.
Suzuki O; Nozawa Y; Abe M
Int J Oncol; 2006 Jan; 28(1):155-60. PubMed ID: 16327992
[TBL] [Abstract][Full Text] [Related]
23. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
[TBL] [Abstract][Full Text] [Related]
24. Role of Galectins in Multiple Myeloma.
Storti P; Marchica V; Giuliani N
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207
[TBL] [Abstract][Full Text] [Related]
25. Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells.
Ashley DM; Bol SJ; Kannourakis G
Leuk Res; 1995 Feb; 19(2):113-20. PubMed ID: 7869739
[TBL] [Abstract][Full Text] [Related]
26. Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context.
Nielsen MI; Stegmayr J; Grant OC; Yang Z; Nilsson UJ; Boos I; Carlsson MC; Woods RJ; Unverzagt C; Leffler H; Wandall HH
J Biol Chem; 2018 Dec; 293(52):20249-20262. PubMed ID: 30385505
[TBL] [Abstract][Full Text] [Related]
27. [Effects of bone marrow stromal cells on the chemotherapeutic sensitivity of acute lymphoblastic leukemia cells].
Wang Y; Han ZX; Zhang JC
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):885-890. PubMed ID: 29262503
[No Abstract] [Full Text] [Related]
28. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells.
Lagana A; Goetz JG; Cheung P; Raz A; Dennis JW; Nabi IR
Mol Cell Biol; 2006 Apr; 26(8):3181-93. PubMed ID: 16581792
[TBL] [Abstract][Full Text] [Related]
29. Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes.
Elola MT; Blidner AG; Ferragut F; Bracalente C; Rabinovich GA
Biochem J; 2015 Jul; 469(1):1-16. PubMed ID: 26173257
[TBL] [Abstract][Full Text] [Related]
30. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
[TBL] [Abstract][Full Text] [Related]
31. Galectins Differentially Regulate the Surface Glycosylation of Human Monocytes.
AbuSamra DB; Martínez-Carrasco R; Argüeso P
Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139007
[TBL] [Abstract][Full Text] [Related]
32. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways.
Bi S; Earl LA; Jacobs L; Baum LG
J Biol Chem; 2008 May; 283(18):12248-58. PubMed ID: 18258591
[TBL] [Abstract][Full Text] [Related]
33. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
[TBL] [Abstract][Full Text] [Related]
34. Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility.
Reesink HL; Sutton RM; Shurer CR; Peterson RP; Tan JS; Su J; Paszek MJ; Nixon AJ
Stem Cell Res Ther; 2017 Nov; 8(1):243. PubMed ID: 29096716
[TBL] [Abstract][Full Text] [Related]
35. Chemokines modulate glycan binding and the immunoregulatory activity of galectins.
Sanjurjo L; Schulkens IA; Touarin P; Heusschen R; Aanhane E; Castricum KCM; De Gruijl TD; Nilsson UJ; Leffler H; Griffioen AW; Elantak L; Koenen RR; Thijssen VLJL
Commun Biol; 2021 Dec; 4(1):1415. PubMed ID: 34931005
[TBL] [Abstract][Full Text] [Related]
36. N-glycans and metastasis in galectin-3 transgenic mice.
More SK; Srinivasan N; Budnar S; Bane SM; Upadhya A; Thorat RA; Ingle AD; Chiplunkar SV; Kalraiya RD
Biochem Biophys Res Commun; 2015 May; 460(2):302-7. PubMed ID: 25791476
[TBL] [Abstract][Full Text] [Related]
37. Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells.
Kihira K; Chelakkot VS; Kainuma H; Okumura Y; Tsuboya N; Okamura S; Kurihara K; Iwamoto S; Komada Y; Hori H
Int J Hematol; 2020 Dec; 112(6):795-806. PubMed ID: 32862292
[TBL] [Abstract][Full Text] [Related]
38. Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factor.
Saint-Lu N; Oortwijn BD; Pegon JN; Odouard S; Christophe OD; de Groot PG; Denis CV; Lenting PJ
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):894-901. PubMed ID: 22267483
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.
Sioud M; Mobergslien A; Boudabous A; Fløisand Y
Int J Oncol; 2011 Feb; 38(2):385-90. PubMed ID: 21165555
[TBL] [Abstract][Full Text] [Related]
40. Lactulose as a novel template for anticancer drug development targeting galectins.
Kishor C; Ross RL; Blanchard H
Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]